Sep. 27, 2018News & Opinions
Drugmaker Novartis has announced plans to cut around 2,200 jobs in Switzerland and exit its site in Grimsby, UK, as it transforms its global manufacturing network and product portfolio.
Sep. 21, 2018Topics
The pharmaceutical industry has gone through two decades of rapid technological innovations. These include combinatorial chemistry, recombinant DNA technology, development of knockout animal models & high throughput screening, and ...
Sep. 10, 2018News & Opinions
Novartis has agreed to sell parts of its Sandoz US portfolio to Aurobindo Pharma USA as the Swiss drugmaker drives ahead with its strategy to focus on higher value medicines.
Aug. 06, 2018News & Opinions
The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the Netherlands in March 2019. The agency said it now expects ...
Jul. 05, 2018News & Opinions
The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was greenlighted in May; however, pharma market watchers are ...
Jul. 02, 2018News & Opinions
In a move that had been widely expected, Swiss drugs giant Novartis has announced that it will spin off its Alcon eye care division into a separate standalone company.
May. 24, 2018News & Opinions
An ill-advised “advisory” deal with the personal attorney of US president Donald Trump continues to plague Swiss drugmaker Novartis. Two weeks ago the company made headlines when the transaction was uncovered during an ...
Apr. 19, 2018News & Opinions
European drugmakers GlaxoSmithKline of the UK and Novartis of Switzerland have agreed to contribute to a nearly $4 billion global research effort to fight drug-resistant strains of malaria.
Apr. 11, 2018News & Opinions
In an all-cash deal expected to close in the second half of this year, Swiss drugs giant Novartis has agreed to pay $8.7 billion for AveXis, a US-based clinical stage gene therapy company.
Mar. 28, 2018News & Opinions
In a move that may explain why GlaxoSmithKline last week turned thumbs down on bidding for Pfizer’s consumer drugs business, the UK’s largest drugmaker has announced plans to buy Novartis’ 35.6% stake in the ...
The latest information directly via newsletter.